Cargando…

Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review

RATIONALE: Locoregional recurrence of breast cancer is a challenging issue for clinicians. Treatment options for unresectable recurrent estrogen receptor positive (ER+) breast cancer in previously irradiated area are limited. Some studies showed concomitant fulvestrant with radiation therapy might i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Jingxian, Guo, Yonghong, Jiang, Xiaoliu, Li, Kai, Fu, Wenbing, Cao, Yali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387012/ https://www.ncbi.nlm.nih.gov/pubmed/32791733 http://dx.doi.org/10.1097/MD.0000000000021344

Ejemplares similares

Efficacy of fulvestrant 500 mg in Chinese postmenopausal women with advanced/recurrent breast cancer and factors associated with prolonged time-to-treatment failure: A retrospective case series
por: Huang, Jian, et al.
Publicado: (2020)

Combination of (125)I brachytherapy and chemotherapy for unresectable recurrent breast cancer: A retrospective control study
por: Tan, Qixing, et al.
Publicado: (2016)

Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy
por: Li, Jin-luan, et al.
Publicado: (2017)

Estrogen Receptor Status Predicts Late-Onset Skeletal Recurrence in Breast Cancer Patients
por: Han, Hyun Ho, et al.
Publicado: (2016)

Reirradiation for Locoregional Recurrent Breast Cancer
por: Fattahi, Sayeh, et al.
Publicado: (2020)

Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy
por: Cao, Lu, et al.
Publicado: (2016)

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
por: LaRiviere, Michael J., et al.
Publicado: (2021)

Fulvestrant May Falsely Increase 17β-Estradiol Levels in Immunoassays: A Case Report of a 57-Year-Old Postmenopausal Patient With Recurrent Estrogen Receptor-Positive Breast Cancer
por: Ding, Jingxian, et al.
Publicado: (2022)

Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report
por: Barchiesi, Giacomo, et al.
Publicado: (2019)

Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer: An observational study in Asian patients
por: Jung, Eun Jung, et al.
Publicado: (2021)

Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma
por: Peng, Jian-Heng, et al.
Publicado: (2019)

A Case Report of Local Recurrence Developing 24 Years After Mastectomy for Breast Cancer Recurrence From Breast Cancer After 24 Years
por: Xiao, Linlin, et al.
Publicado: (2016)

Recurrent malignant phyllodes tumor of the breast: A case report
por: Wang, Qinqin, et al.
Publicado: (2017)

Facing the CDK4/6i resistance dilemma in patients with breast cancer, exploration of the resistance mechanism and possible reverse strategy: A narrative review
por: Wu, Jiayi, et al.
Publicado: (2022)

Association between depressive disorders and risk of breast cancer recurrence after curative surgery
por: Chen, Shaw-Ji, et al.
Publicado: (2016)

Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer
por: Choi, Eun Jung, et al.
Publicado: (2016)

Discordance of immunohistochemical markers between primary and recurrent or metastatic breast cancer: A retrospective analysis of 107 cases
por: Peng, Li, et al.
Publicado: (2020)

Immediate breast reconstruction using latissimus dorsi muscular flap: A retrospective study of Chinese patients with breast cancer
por: Liu, Qiuming, et al.
Publicado: (2021)

Magnetic resonance imaging and contrast-enhanced ultrasound findings of a recurrent primary breast angiosarcoma: A case report
por: Yang, Ou Ou, et al.
Publicado: (2021)

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
por: Choi, Ji Soo, et al.
Publicado: (2016)

Change of HER2 status during disease recurrence predicts good prognosis for primary squamous cell carcinoma of the breast: A case report
por: Cao, Yong, et al.
Publicado: (2019)

Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis
por: Sun, Xi, et al.
Publicado: (2017)

Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis
por: Ding, Yunfeng, et al.
Publicado: (2021)

High expression of MORC2 predicts worse neoadjuvant chemotherapy efficacy in triple negative breast cancer
por: Liao, Xiaohong, et al.
Publicado: (2023)

Magnetic resonance imaging in screening women at high risk of breast cancer: A meta-analysis
por: Ding, Wu, et al.
Publicado: (2023)

Combining the tumor abnormal protein test with tests for carcinoembryonic antigens, cancer antigen 15–3, and/or cancer antigen 125 significantly increased their diagnostic sensitivity for breast cancer
por: Chen, Rui, et al.
Publicado: (2020)

Spontaneous pneumothorax due to bronchopleural fistula following reirradiation for locoregionally recurrent squamous cell lung cancer
por: Ota, Takayo, et al.
Publicado: (2016)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis
por: Lu, Demin, et al.
Publicado: (2016)

Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer
por: Park, Vivian Youngjean, et al.
Publicado: (2016)

Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer
por: Choi, Min-Young, et al.
Publicado: (2016)

Association Between Insulin Resistance and Luminal B Subtype Breast Cancer in Postmenopausal Women
por: Nam, Sanggeun, et al.
Publicado: (2016)

Does Breast Magnetic Resonance Imaging Combined With Conventional Imaging Modalities Decrease the Rates of Surgical Margin Involvement and Reoperation?: A Case–Control Comparative Analysis
por: Lai, Hung-Wen, et al.
Publicado: (2016)

Association Between Single Nucleotide Polymorphisms in DNA Polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population: A STROBE-Compliant Observational Study
por: Dai, Zhi-Jun, et al.
Publicado: (2016)

Bioimpedance spectroscopy can precisely discriminate human breast carcinoma from benign tumors
por: Du, Zhenggui, et al.
Publicado: (2017)

Better survival in PMRT of female breast cancer patients with >5 negative lymph nodes: A population-based study
por: Wang, Haiyong, et al.
Publicado: (2017)

Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer
por: Lim, Chae Hong, et al.
Publicado: (2016)

Risk assessment model for invasive breast cancer in Hong Kong women
por: Wang, Feng, et al.
Publicado: (2016)

Social isolation and cancer management after the 2011 triple disaster in Fukushima, Japan: A case report of breast cancer with patient and provider delay
por: Ozaki, Akihiko, et al.
Publicado: (2016)

Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study
por: Wen, Jiahuai, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qjofba0br9h9qh7juoeltno12s